Guardant Health officer nets shares from RSU vesting
Guardant Health, Inc. Chief People Officer Terilyn J. Monroe reported routine equity compensation activity tied to restricted stock units.
Rhea-AI Filing Summary
Guardant Health, Inc. Chief People Officer Terilyn J. Monroe reported routine equity compensation activity tied to restricted stock units. On April 1, 2026, she acquired 8,019 shares of common stock upon vesting and related derivative exercises, then had 4,187 shares withheld by the company to cover tax obligations at $91.15 per share. After these transactions, she directly held 24,822 shares of common stock. The filing reflects compensation and tax withholding mechanics rather than open-market buying or selling.
Positive
- None.
Negative
- None.
Insider Trade Summary
8,019 shares exercised/converted
Exercise
5 txns
Insider
Monroe Terilyn J.
Role
Chief People Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 2,660 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 5,359 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,660 | $0.00 | $0.00 |
| Exercise | Common Stock | 5,359 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 4,187 | $91.15 | $382K |
Holdings After Transaction:
Restricted Stock Units — 26,838 contracts (Direct);
Common Stock — 24,822 shares (Direct)
Footnotes (4)
- F1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- F2. This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- F3. Not applicable for Restricted Stock Units.
- F4. This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Key Figures
RSU shares vested: 8,019 shares
Tax withholding shares: 4,187 shares
Tax withholding price: $91.15 per share
+3 more
6 metrics
RSU shares vested
8,019 shares
Restricted stock units converting into common stock on April 1, 2026
Tax withholding shares
4,187 shares
Shares retained by Guardant Health to cover tax obligations
Tax withholding price
$91.15 per share
Price used for shares withheld for Monroe’s tax liability
Post-transaction holdings
24,822 shares
Common stock directly held by Monroe after April 1, 2026 transactions
First RSU tranche
2,660 shares
Common shares delivered from one RSU award on April 1, 2026
Second RSU tranche
5,359 shares
Common shares delivered from another RSU award on April 1, 2026
Key Terms
Restricted Stock Units, tax withholding obligations, vests in equal quarterly installments, restricted stock unit award
4 terms
Restricted Stock Units financial
"This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting"
vests in equal quarterly installments financial
"the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter"
restricted stock unit award financial
"This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period."
A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Guardant Health (GH) Chief People Officer report in this Form 4?
The Form 4 shows Chief People Officer Terilyn J. Monroe received common shares from vested restricted stock units. These awards are part of her compensation and were settled in stock rather than cash, reflecting normal equity-based pay practices at Guardant Health.
What do the footnotes say about Monroe’s restricted stock unit awards at Guardant Health?
The footnotes explain Monroe’s RSU awards were granted in November 2024 and March 2025, each vesting over three years. One vests 33% on an initial date with the remaining 67% in equal quarterly installments over the subsequent two-year period, outlining ongoing scheduled vesting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
